Epstein Secrets

evices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

fication of C=tegory A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and V=riola Virus Das S.1, Rundell M.S.2, Mirza A.H.2, Pingle M.R.2, Shigyo K.1, Garrison=A.R.3, Paragas J.4, Smith S. K.5, Olson V. A.5, Larone D.H.2, 6,&=bsp;Spitzer E.D.7, Barany F.2 and Golightly L.M.1, 2 1. Department

ricated devices that w=ll allow for electronic detection, obviating the need for expens=ve hardware used in most fluorescent detection schemes (i.e. Taqman a=says). As such, we are poised to combine these technologie= for rapidly identifying and providing quantitative viral load fo= all the VHF, Variol

athogens: Agents of Viral Hemorrhagic Fever and=Variola Virus 2 EFTA_R1_01775797 EFTA02592732 Das S.1, Rundell M.S.2, Mirza A.H.2, Pingle M.R.2, Shigyo K.1, Garriso= A.R.3, Paragas J.4, Smith S. K.5, Olson V. A.5, Larone D.H.2, 6= Spitzer E.D.7, Barany F.2 and Golightly L.M.1, 2 1. Department of Me

devices suitable f=r working in developing countries, and may be powered and run by a cell phone or smart device. • Current CDC approved EZ1-RT-P=R Taqman assay has LOD of 5,000 PFU/ml. This works when patient is&nbs=;febrile, i.e. has overt symptoms and may be contagious. • Next level of assay needs

fication of C=tegory A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and V=riola Virus Das 5.1, Rundell M.S.2, Mirza A.H.2, Pingle M.R.2, Shigyo K.1, Garrison=A.R.3, Paragas J.4, Smith S. K.5, Olson V. A.5, Larone D.H.2, 6,&=bsp;Spitzer E.D.7, Barany F.2 and Golightly L.M.1, 2 1. Department